SOUTH SAN FRANCISCO, Calif., July 7, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nas

Dr. Hannah has decades of oncology drug development experience and has served on Rigel's Board of Di

Rigel Pharmaceuticals trades at an attractive valuation after a 35% pullback, with a market cap just

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hemat

SOUTH SAN FRANCISCO, Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL

SOUTH SAN FRANCISCO, Calif., May 27, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL)

Oral presentation at ASCO Annual Meeting to feature final data from the Phase 3 AcceleRET-Lung clini

SOUTH SAN FRANCISCO, Calif., May 14, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL)

Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Phar

Rigel Pharmaceuticals, Inc. (RIGL) M&A Call Transcript

Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) stock is trading higher on Tuesday as the company is enteri

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer fol

Arvinas, Inc. (NASDAQ:ARVN), a biotechnology company creating a new class of drugs based on targeted

VEPPANU has a novel mechanism of action, is the first and only FDA-approved PROTAC and has the poten

Rigel Pharmaceuticals, Inc. (RIGL) Q1 2026 Earnings Call Transcript

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.44 per share, missing the Zacks

First quarter 2026 total revenues of $58.8 million, including net product sales of $54.9 million and

Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings

SOUTH SAN FRANCISCO, Calif., April 28, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIG

Investors need to pay close attention to RIGL stock based on the movements in the options market lat

Rigel Pharmaceuticals (RIGL) is upgraded to a speculative Buy as profitability and product momentum

SOUTH SAN FRANCISCO, Calif., April 7, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Na

Pralsetinib induced robust and durable responses with a manageable safety profile, reinforcing the b

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL - Get Free Report) have been assigned a consensu

U.S. stocks up on Wednesday with NASDAQ gaining 0.85%. ISM services PMI rose to 56.1. VCI Global Ltd

The three major indices were mostly flat in midday trading Wednesday with the S&P 500 and Nasdaq

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effe

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Wednesday